Seqens, a provider of pharmaceutical synthesis and specialty ingredients, has opened a 366,000-square-foot lab close to Paris, France that will serve as the company’s center of excellence in its Porcheville facility. Known as SEQENS’Lab, the new lab offers a package of R&D services, dedicated to accelerate projects from early research and development stages to production and sales for clients in key markets including pharmaceuticals, cosmetics and specialty ingredients.   Agnès Pannier...